Scientific Program

*It is based on the local time of Seoul, Korea (UTC/ GMT +9:00) Updated as of September 7

November 15 (Wed)

Educational Session 1- Spatial genomics and computational histopathology

Date & Time 11/15(Wed) 13:00 – 14:40 Place Sapphire Ballroom (3F)
  • ·
  • Computational histopathology and AI enabled diagnostics: Where are we today and future directions

    Anil V. Parwani (The Ohio State University Wexner Medical Center, Columbus, Ohio, USA)

  • ·
  • Technical advances in spatial transcriptomics and single nucleus RNA seq by Fixative eXchange (FX)-seq for clinical FFPE cancer samples

    Chang Ho Sohn (Yonsei University Advanced Science Institute, Korea)

  • ·
  • The emerging landscape of single-cell and spatial multi-omics

    Melanie Spears (Ontario Institute for Cancer Research, Toronto, Ontario, Canada)

  • ·
  • Navigating the spatial genomics landscape: A look into the current status

    Jungmin Choi (Korea University College of Medicine, Korea)

Educational Session 2- New insights of precancerous to cancerous path

Date & Time 11/15 (Wed) 15:00 – 16:40 Place Sapphire Ballroom (3F)
  • ·
  • Evolutionary therapy

    Alexander R.A. Anderson (Moffitt Cancer Center, Tampa, Florida, USA)

  • ·
  • ITF2: A potential target for suppressing colitis-associated cancer progression

    Hyun-Woo Shin (Seoul National University College of Medicine, Korea)

  • ·
  • Improved diagnosis of endometrial precancers

    Diego H. Castrillon (UT Southwestern Medical Center, Dallas, Texas, USA)

  • ·
  • Tracing cellular dynamics during intestinal tumorigenesis and tissue repair

    Min Kyu Yum (Korea Advanced Institute of Science and Technology, Korea)

November 16 (Thu)

Keynote Lecture

Date & Time 11/16 (Thu) 10:30 – 11:10 Place Crystal Ballroom (2F)
  • ·
  • Early detection of cancer using cell-free DNA fragmentomes

    Victor E. Velculescu (Johns Hopkins University School of Medicine, Baltimore, Maryland, USA)

Plenary Session 1- Precision early detection and monitoring

Date & Time 11/16 (Thu) 08:30 – 10:10 Place Crystal Ballroom (2F)
  • ·
  • Circulating tumor DNA analysis for detection and monitoring of lung cancer

    Maximilian Diehn (Stanford University, Stanford, California, USA)

  • ·
  • Cancer detection and monitoring using whole genome methylation sequencing

    Duhee Bang (Yonsei University College of Science, Korea) 

  • ·
  • Hereditary cancer surveillance using cell-free DNA sequencing

    Trevor J. Pugh (University of Toronto, Toronto, Ontario, Canada)

  • ·
  • Multi cancer early detection by Exosome-SERS-AI

    Yeonho Choi (Korea University School of Biomedical Engineering, Korea)

Plenary Session 2- Emerging radiation technology and radiobiology: Heavy ion therapy and FLASH

Date & Time 11/16 (Thu) 12:30 – 14:10 Place Crystal Ballroom (2F)
  • ·
  • Imaging and quality assurance for emerging radiation technologies: Experiences of IROC for the NCI NCTN and beyond

    Michael V. Knopp (University of Cincinnati, Cincinnati, Ohio, USA)

  • ·
  • Reinventing radiobiology in the light of FLASH radiotherapy

    Won Il Jang (Korea Cancer Center Hospital, Korea)

  • ·
  • Preclinical studies with proton FLASH radiotherapy in mouse models and canines

    Constantinos Koumenis (University of Pennsylvania, Philadelphia, Pennsylvania, USA)

  • ·
  • Repair of heavy ion radiation-induced complex DNA double-strand breaks

    Kei-ichi Takata (Institute for Basic Science, Korea)

Plenary Session 3- Targeting tumor microenvironments in immune-oncology

Date & Time 11/16 (Thu) 14:30 – 16:10 Place Crystal Ballroom (2F)
  • ·
  • Metabolic vulnerabilities as therapeutic targets in ovarian cancer

    Kunle Odunsi (University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, USA)

  • ·
  • Tumor-associated monocytes and neutrophils: Targets for immunotherapy?

    Keehoon Jung (Seoul National University College of Medicine, Korea)

  • ·
  • Targeting cancer-associated fibroblasts to enhance immunotherapy: Characterising heterogeneity and exploiting plasticity

    Gareth Thomas (University of Southampton, Southampton, England)

  • ·
  • How is tumor immunity regulated in fibrotic gastric cancers?

    Hoon Hur (Ajou University School of Medicine, Korea)

Luncheon Symposium 1 - Boryung

Date & Time 11/16 (Thu) 11:20 – 12:00 Place Crystal Ballroom (2F)
  • ·
  • State-of-the-art neo/adjuvant treatment in pancreatic cancer: guidance for oncologist

    Hyehyun Jeong (Ulsan University College of Medicine, Korea)

Luncheon Symposium 2 - AstraZeneca

Date & Time 11/16 (Thu) 11:20 – 11:40 Place Sapphire Ballroom (3F)
  • ·
  • Present and future of osimertinib as the backbone therapy of EGFRm NSCLC

    Min Hee Hong (Yonsei University College of Medicine, Korea)

November 17 (Fri)

Waun Ki Hong Memorial Lecture

Date & Time 11/17 (Fri) 11:40 – 12:20 Place Crystal Ballroom (2F)
  • ·
  • The cancer dependency map and beyond

    William C. Hahn (Harvard Medical School, Boston, Massachusetts, USA)

Plenary Session 4- 2023 Cancer Progress in US and South Korea

Date & Time 11/17 (Fri) 08:30 – 09:30 Place Crystal Ballroom (2F)
  • ·
  • AACR Cancer Progress Report 2023

    Rajarshi Sengupta (American Association for Cancer Research, Philadelphia, Pennsylvania, USA)

  • ·
  • KCA Cancer Report 2023

    Tae-Yong Kim (Seoul National University College of Medicine, Korea)

Plenary Session 5- Clinical trials in the precision oncology era

Date & Time 11/17 (Fri) 09:40 – 11:20 Place Crystal Ballroom (2F)
  • ·
  • Measuring apoptotic priming with BH3 profiling: From laboratory tool to clinical diagnostic

    Anthony G. Letai (Dana-Farber Cancer Institute, Boston, Massachusetts, USA)

  • ·
  • Update of K-MASTER: The first Korean precision oncology initiative

    Kyong Hwa Park (Korea University College of Medicine, Korea)

  • ·
  • Patient-derived tumor organoid models for functional precision medicine

    Alice Soragni (University of California, Los Angeles, California, USA)

  • ·
  • A pragmatic precision medicine platform: KOSMOS trial

    Sun Young Kim (University of Ulsan College of Medicine, Korea)

Plenary Session 6- Aging and cancer senescence

Date & Time 11/17 (Fri) 13:40 – 15:20 Place Crystal Ballroom (2F)
  • ·
  • Regulation of telomerase in stem cells and cancer

    Steven Artandi (Stanford Cancer Institute, Stanford, California, USA)

  • ·
  • Senescent tumor cell; The novel modulator of the cancer microenvironment

    Tae Jun Park (Ajou University School of Medicine, Korea)

  • ·
  • Exploiting senescence to treat liver cancer

    M. Celeste Simon (Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania, USA)

  • ·
  • The transcriptional hallmarks of oncogene-induced senescence: A combined meta-analysis and machine learning approach

    Sung Young Kim (Konkuk University School of Medicine, Korea)

Plenary Session 7- Cancer plasticity and epigenetics

Date & Time 11/17 (Fri) 15:40 – 17:20 Place Crystal Ballroom (2F)
  • ·
  • Highly multiplexed imaging for precision breast immuno-oncology

    Raza Ali (Cancer Research UK, London, England)

  • ·
  • Dissecting cellular heterogeneity and plasticity of lung cancer

    Jong Kyoung Kim (Pohang University of Science and Technology, Korea)

  • ·
  • Understanding plasticity and histological transformation during emergence of resistance to targeted therapies

    Álvaro Quintanal-Villalonga (Memorial Sloan Kettering Cancer Center, New York, New York, USA)

  • ·
  • Anchorage plasticity reconstructs the metastatic cascade

    Hyun Woo Park (Yonsei University College of Life Science & Biotechnology, Korea)

Luncheon Symposium 3 - MSD

Date & Time 11/17 (Fri) 12:30 – 13:10 Place Crystal Ballroom (2F)
  • ·
  • Pembrolizumab unveiled: Illuminating its role in esophageal, GEJ and gastric cancer as a shining star in the dark

    Ho Jung An (The Catholic University of Korea, St. Vincent's Hospital, Korea)